Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tugce Canavar Yildirim

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Immunology|March 27, 2024
Immunogenicity and protective capacity of a CpG ODN adjuvanted alum adsorbed bivalent meningococcal outer membrane vesicle vaccineTugce Canavar Yildirim, Yasemin Ozsurekci, Muzaffer Yildirim, et al.
International Immunology|October 22, 2019
A suppressive oligodeoxynucleotide expressing TTAGGG motifs modulates cellular energetics through the mTOR signaling pathwayVolkan Yazar, Gizem Kilic, Ozlem Bulut, et al.
Immunology Letters|August 21, 2021
TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in miceMuzaffer Yildirim, Tugce Canavar Yildirim, Nilsu Turay, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2026
Circulating Extracellular Vesicles Drive Innate Immune Dysregulation in MIS-CTugce Canavar Yildirim, Yasemin Ozsurekci, Muzaffer Yildirim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 17, 2024
Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesiclesTamer Kahraman, Gozde Gucluler Akpinar, Muzaffer Yildirim, et al.
Vaccine|February 1, 2025
A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccineIsmail Cem Yilmaz, Emre Mert Ipekoglu, Berfu Saraydar Golcuklu, et al.
Journal of Extracellular Vesicles|March 26, 2026
Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against LeishmaniasisIsmail Cem Yilmaz, Ibrahim Tokmak, Muzaffer Yildirim, et al.
Scientific Reports|March 30, 2023
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastorisSibel Kalyoncu, Semiramis Yilmaz, Ayca Zeybek Kuyucu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Immunology|March 27, 2024
Immunogenicity and protective capacity of a CpG ODN adjuvanted alum adsorbed bivalent meningococcal outer membrane vesicle vaccineTugce Canavar Yildirim, Yasemin Ozsurekci, Muzaffer Yildirim, et al.
International Immunology|October 22, 2019
A suppressive oligodeoxynucleotide expressing TTAGGG motifs modulates cellular energetics through the mTOR signaling pathwayVolkan Yazar, Gizem Kilic, Ozlem Bulut, et al.
Immunology Letters|August 21, 2021
TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in miceMuzaffer Yildirim, Tugce Canavar Yildirim, Nilsu Turay, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2026
Circulating Extracellular Vesicles Drive Innate Immune Dysregulation in MIS-CTugce Canavar Yildirim, Yasemin Ozsurekci, Muzaffer Yildirim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 17, 2024
Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesiclesTamer Kahraman, Gozde Gucluler Akpinar, Muzaffer Yildirim, et al.
Vaccine|February 1, 2025
A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccineIsmail Cem Yilmaz, Emre Mert Ipekoglu, Berfu Saraydar Golcuklu, et al.
Journal of Extracellular Vesicles|March 26, 2026
Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against LeishmaniasisIsmail Cem Yilmaz, Ibrahim Tokmak, Muzaffer Yildirim, et al.
Scientific Reports|March 30, 2023
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastorisSibel Kalyoncu, Semiramis Yilmaz, Ayca Zeybek Kuyucu, et al.
Pageof 1